| Literature DB >> 36008844 |
Yifan Zhang1,2, Li Yang3, Yanming Xu4, Ming Zhang5,6, Yuzhu Gao1,2, Dan Zhang3, Yunhan Tao1, Hanyue Xu1,2, Yi Chen1,2.
Abstract
BACKGROUND: Parkinson's disease (PD) is one of the most common neurodegenerative diseases in the aging population. Previous literature has reported thinning of the retinal nerve fiber layer, ganglion cell layer, inner plexiform layer, and photoreceptor layer in PD patients. However, very few studies have used swept-source optical coherence tomography (SS-OCT) to study the choroid and choriocapillaris vascular changes in PD and their correlations with altered contrast sensitivity.Entities:
Keywords: Choriocapillaris; Optical coherence tomography angiography; Parkinson’s disease; Swept-source optical coherence tomography
Mesh:
Year: 2022 PMID: 36008844 PMCID: PMC9404633 DOI: 10.1186/s13195-022-01054-z
Source DB: PubMed Journal: Alzheimers Res Ther Impact factor: 8.823
Fig. 1SS-OCTA image of the outer retina. A SLO and en face image of the outer retina. Outer retinal thickness was measured with ETDRS, and thickness data of each area was generated by the built-in measurement tool. B Thickness map of the outer retina. The blue areas indicate thinning in the layer of interests. C The segmentation of the outer retina was marked between the two blue lines
Fig. 2SS-OCTA image of the choriocapillaris. A SLO and en face image of the choriocapillaris. B Choriocapillaris flow density was measured with ETDRS. C Choriocapillaris was defined as 20 μm below Bruch’s membrane, and the automatically segmented choriocapillaris was marked between the blue lines. The retinal flow signal is shown in red, and the choroid flow signal was labeled shown in orange
Fig. 3SS-OCTA image of the choroid. A SLO and en face image of the choroid. B Choroid flow signal demonstrated in the en face image. C B- scan of the fovea. Haller’s and Sattler’s layer was marked in orange
Baseline demographics and disease characteristics of PD patients and healthy controls
| PD patients ( | Controls ( | ||
|---|---|---|---|
| Male | 26 | 50 | 1 |
| Age, years | 57.92 ± 8.14 | 56.63 ± 6.42 | 0.281 |
| Disease duration, years | 2.47 ± 1.51 | - | - |
| SE, D | − 0.28 ± 0.85 | − 0.24 ± 0.96 | 0.88 |
| BCVA, Log MAR | 0.93 ± 0.15 | 0.95 ± 0.17 | 0.3191 |
| IOP, mm Hg | 13.84 ± 3.09 | 14.26 ± 1.84 | 0.781 |
| Smoking status | 3 | 7 | 0.772 |
| Alcohol use | 2 | 3 | 1 |
| H-Y scale | 1.52 ± 0.65 | - | - |
| UPDRS | 26.32 ± 15.85 | - | - |
SE spherical equivalent, BCVA best-corrected visual acuity, IOP intraocular pressure, H-Y Scale Hoehn-Yahr scale, UPDRS Unified Parkinson’s disease rating scale
Comparison of outer retinal and choroidal thickness of PD patients and healthy controls (μm)
| Patients | Control | ||
|---|---|---|---|
| Outer retinal thickness | |||
| 0–1 mm | 187.1 ± 14.3 | 190.9 ± 11.5 | 0.018 |
| 0–3 mm | 170.1 ± 12.5 | 175 ± 8.6 | < 0.0001 |
| 0–6 mm | 151.7 ± 12.8 | 156.1 ± 7.8 | 0.002 |
| Superior | 152.7 ± 14.7 | 158.2 ± 8.2 | < 0.0001 |
| Temporal | 151.9 ± 12.8 | 156.5 ± 7.8 | 0.001 |
| Inferior | 145.6 ± 12.6 | 149 ± 8 | 0.012 |
| Nasal | 152.8 ± 13.1 | 156.5 ± 8.9 | 0.009 |
| Choroidal thickness | |||
| 0–1 mm | 313.3 ± 84.3 | 333.5 ± 76.3 | 0.049 |
| 0–3 mm | 306.4 ± 81.6 | 326.2 ± 71.9 | 0.043 |
| 0–6 mm | 289.9 ± 76.9 | 307.8 ± 63.9 | 0.044 |
| Superior | 314.3 ± 83 | 328.9 ± 64.9 | 0.15 |
| Temporal | 291.2 ± 79.6 | 313.7 ± 70.7 | 0.019 |
| Inferior | 290.8 ± 79.5 | 313.1 ± 73.2 | 0.023 |
| Nasal | 260.6 ± 86.4 | 272.6 ± 74.4 | 0.238 |
Comparison of choriocapillaris flow density, CVI, and CVV of PD patients and healthy controls
| Patients | Control | ||
|---|---|---|---|
| CC flow density (%) | |||
| 0–1 mm | 70.48 ± 10.11 | 76.29 ± 10.98 | < 0.0001 |
| 0–3 mm | 73.64 ± 5.89 | 76.95 ± 6.59 | < 0.0001 |
| 0–6 mm | 76.17 ± 3.68 | 78.26 ± 5.04 | < 0.0001 |
| Superior | 77.45 ± 4.15 | 79.45 ± 5.28 | 0.001 |
| Temporal | 74.51 ± 3.14 | 75.77 ± 2.81 | 0.062 |
| Inferior | 77.18 ± 3.77 | 79.49 ± 5.41 | < 0.0001 |
| Nasal | 76.32 ± 4.29 | 77.35 ± 5.45 | 0.082 |
| CVI | 0 ± 0 | ||
| 0–1 mm | 0.38 ± 0.13 | 0.37 ± 0.07 | 0.871 |
| 0–3 mm | 0.34 ± 0.12 | 0.37 ± 0.07 | 0.03 |
| 0–6 mm | 0.31 ± 0.11 | 0.35 ± 0.07 | 0.003 |
| Superior | 0.31 ± 0.12 | 0.36 ± 0.08 | 0.01 |
| Temporal | 0.3 ± 0.11 | 0.34 ± 0.08 | 0.006 |
| Inferior | 0.31 ± 0.12 | 0.36 ± 0.08 | 0.001 |
| Nasal | 0.31 ± 0.12 | 0.34 ± 0.09 | 0.127 |
| CVV (mm3) | 0 ± 0 | ||
| 0–1 mm | 0.11 ± 0.05 | 0.11 ± 0.03 | 0.94 |
| 0–3 mm | 0.85 ± 0.4 | 0.91 ± 0.37 | 0.151 |
| 0–6 mm | 2.89 ± 1.43 | 3.27 ± 1.12 | 0.023 |
| Superior | 0.74 ± 0.37 | 0.87 ± 0.31 | 0.002 |
| Temporal | 0.68 ± 0.34 | 0.78 ± 0.29 | 0.008 |
| Inferior | 0.71 ± 0.38 | 0.82 ± 0.33 | 0.017 |
| Nasal | 0.67 ± 0.39 | 0.69 ± 0.33 | 0.485 |
CC choriocapillaris, CVI choroidal vascular index, CVV choroidal vascular volume
Contrast sensitivity test in PD patients and healthy controls
| PD patients | Controls | ||
|---|---|---|---|
| cpd 3 | 1.39 ± 0.23 | 1.56 ± 0.22 | < 0.001 |
| cpd 6 | 1.54 ± 0.26 | 1.71 ± 0.21 | < 0.001 |
| cpd 12 | 1.00 ± 0.2 | 1.25 ± 0.32 | < 0.001 |
| cpd 18 | 0.87 ± 0.24 | 1.02 ± 0.18 | < 0.001 |
cpd cycles per degree
Fig. 4Correlations of contrast sensitivity and outer retinal thickness at 3, 6, 12, and 18 cycles per degree